We are live on ! Find out more
EXAS

Exact Sciences

Delisted

EXAS was delisted on the 20th of March, 2026.

517 hedge funds and large institutions have $14B invested in Exact Sciences in 2020 Q3 according to their latest regulatory filings, with 79 funds opening new positions, 165 increasing their positions, 179 reducing their positions, and 73 closing their positions.

New
Increased
Maintained
Reduced
Closed

21% more capital invested

Capital invested by funds: $11.5B → $14B (+$2.45B)

3.29% more ownership

Funds ownership: 88.48%91.77% (+3.3%)

8% more first-time investments, than exits

New positions opened: 79 | Existing positions closed: 73

1% more call options, than puts

Call options by funds: $248M | Put options by funds: $246M

1% more funds holding

Funds holding: 513517 (+4)

0% more funds holding in top 10

Funds holding in top 10: 1212 (0)

8% less repeat investments, than reductions

Existing positions increased: 165 | Existing positions reduced: 179

Holders
517
Holders Change
+4
Holders Change %
+0.78%
% of All Funds
10.43%
Holding in Top 10
12
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.24%
New
79
Increased
165
Reduced
179
Closed
73
Calls
$248M
Puts
$246M
Net Calls
+$2.2M
Net Calls Change
+$35.9M

EXAS Hedge Fund Activity: Q3 2020 in Review

517 of the 4,957 institutional investors tracked by Wall St. Rank reported a position in Exact Sciences (EXAS) for Q3 2020, worth a combined $14B — up 21% from $11.5B a quarter earlier.

Buyers outnumbered sellers: 79 funds opened new EXAS positions and 73 closed out — a net gain of 6 holders — while 165 added to existing stakes and 179 trimmed.

The largest buyer was Capital World Investors, adding an estimated $556M. The largest seller was T. Rowe Price Associates, cutting an estimated $121M.

  • 517 institutional investors held Exact Sciences (EXAS) as of Q3 2020, up from 513 in Q2 2020.
  • Funds reported $14B of Exact Sciences stock for Q3 2020, up 21% quarter-over-quarter.
  • 79 funds opened new Exact Sciences positions in Q3 2020 and 73 closed out, a net change of +6 holders.
  • The largest Exact Sciences buyer in Q3 2020 was Capital World Investors, an estimated $556M added.
  • The largest Exact Sciences seller in Q3 2020 was T. Rowe Price Associates, an estimated $121M sold.

Based on aggregated 13F filings for Q3 2020.